Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | PDK1 | Q15118 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL820347 | 0.80 | ALDH1A1 (0.37) | ALDH1A1 | |
| SCHEMBL1783303 | 0.79 | — | — | |
| SCHEMBL12758702 | 0.78 | ALDH1A1 (0.36) | ALDH1A1 | |
| SCHEMBL990032 | 0.77 | — | — | |
| SCHEMBL28567475 | 0.77 | — | — | |
| SCHEMBL991379 | 0.75 | ALDH1A1 (0.45) | ALDH1A1SMN1; SMN2 | |
| SCHEMBL12391544 | 0.74 | TSHR (0.47) | ALDH1A1SMN1; SMN2TSHR | |
| SCHEMBL819773 | 0.74 | ALDH1A1 (0.33) | ALDH1A1 | |
| SCHEMBL6438635 | 0.74 | — | — | |
| SCHEMBL10884022 | 0.72 | THRB (0.40) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8889893-B2 | Process for the manufacture of 1,2-epoxy-3-chloropropane | Solvay (SociétéAnonyme) (BE) | 2014-11-18 | — | — | US | disclosed |
| US-20100331557-A1 | PROCESS FOR THE MANUFACTURE OF 1,2-EPOXY-3-CHLOROPROPANE | SOLVAY (SOCIETE ANONYME) (BE) | 2010-12-30 | — | — | US | disclosed |
| US-7834202-B2 | by reacting allyl chloride (comprises 1,5-hexadiene) and hydrogen peroxide in presence of zeolite catalyst and solvent | SOLVAY (SOCIETE ANONYME) (BE) | 2010-11-16 | — | — | US | disclosed |
| US-20080026486-A1 | Assay Methods, Materials and Preparations | AKUBIO LIMITED (GB) | 2008-01-31 | — | — | US | disclosed |
| US-20080026486-A1 | Assay Methods, Materials and Preparations | AKUBIO LIMITED (GB) | 2008-01-31 | — | — | US | disclosed |
| US-20060167288-A1 | by reacting allyl chloride (comprises 1,5-hexadiene) and hydrogen peroxide in presence of zeolite catalyst and solvent | SOLVAY (SOCIETE ANONYME) (BE) | 2006-07-27 | — | — | US | disclosed |
| EP-1575928-A1 | PROCESS FOR THE MANUFACTURE OF 1,2-EPOXY-3-CHLOROPROPANE | SOLVAY (Société Anonyme) (BE) | 2005-09-21 | — | — | EP | disclosed |
| WO-2004043941-A1 | PROCESS FOR THE MANUFACTURE OF 1,2-EPOXY-3-CHLOROPROPANE | Solvay (Société Anonyme) (BE) | 2004-05-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080026486-A1 | Assay Methods, Materials and Preparations | SCLY, ZYX, TST | ALDH1A1 2598/4885SMN1; SMN2 1261/4885TSHR 80/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.